We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

N-Nitroso Deferasirox EP Impurity F

Chemical Structure
Specifications
Product name
N-Nitroso Deferasirox EP Impurity F
Other Name
N-Nitroso 4-Hydrazinobenzoic Acid
SRC CAT No
SRC-N014145
CAS No
NA
Mol.F.
C7H7N3O3
Mol.Wt.
181.15 g/mol
Related CAS No.
NA
Inv Status
IN STOCK
Chemical Structure
Chemical Structure
view file icon VIEW COA

Chemical Name
4-(1-nitrosohydrazinyl)benzoic acid

HSN Code
38229010
Synonym
N-Nitroso Deferasirox EP Impurity F | N-Nitroso 4-Hydrazinobenzoic Acid

Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.N-Nitroso 4-Hydrazinobenzoic Acid can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Nitrosamines . N-Nitroso 4-Hydrazinobenzoic Acid is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.

N-Nitroso 4-Hydrazinobenzoic Acid is also known as  N-Nitroso Deferasirox EP Impurity F chemically represented as 4-(1-nitrosohydrazinyl)benzoic acid . Synchemia is the leading manufacturing and exporter of N-Nitroso 4-Hydrazinobenzoic Acid. We supply N-Nitroso 4-Hydrazinobenzoic Acid with detailed characterization data compliance with regulatory guidelines.